COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)

A Baruchel (1, 2) , Y Bertrand (3) , N Boissel (1, 4) , B Brethon (1, 2) , S Ducassou (5) , V Gandemer (6) , C Halfon-Domenech (3) , T Leblanc (1, 2) , G Leverger (7) , G Michel (8) , A Petit (7) , Af Ray-Lunven (1) , Ps Rohrlich (9) , P Schneider (10) , N Sirvent (11) , M Strullu (1, 2)

1 UPCité - Université Paris Cité
2 Hôpital Robert Debré
3 Hôpital Edouard Herriot [CHU - HCL]
4 AP-HP - Hopital Saint-Louis [AP-HP]
5 Groupe hospitalier Pellegrin
6 CHU Pontchaillou [Rennes]
7 SU - Sorbonne Université
8 CHU Marseille
9 CHU Nice - Centre Hospitalier Universitaire de Nice
10 CHU Rouen
11 CHU - Hôpital Lapeyronie [Montpellier]

Since the emergence of the SARS-CoV-2 infection many recommendations have been made. However the very nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations even if data for this population are still scarce. They may have to evolve according to the rapid evolution of knowledge on COVID-19.

Domains: Life Sciences [q-bio]; Life Sciences [q-bio]; Cancer

A Baruchel, Y Bertrand, N Boissel, B Brethon, S Ducassou, et al.. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE). Bulletin du Cancer, 2020, ⟨10.1016/j.bulcan.2020.04.003⟩. ⟨hal-02638972⟩